1
|
Fleming GF, Ronnett BM and Seidman J:
Epithelial ovarian cancer. Principles and Practice of Gynecologic
Oncology. Barakat RR, Markman M and Randall ME: 5th edition.
Lippincott Williams & Wilkins; Philadelphia, PA: pp. 763–836.
2009
|
2
|
Chan JK, Cheung MK, Husain A, et al:
Patterns and progress in ovarian cancer over 14 years. Obstet
Gynecol. 108:521–528. 2006.PubMed/NCBI
|
3
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2009. CA Cancer J Clin. 59:225–249. 2009. View Article : Google Scholar
|
4
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
5
|
Sugawa T, Umesaki N, Yajima A, et al: A
group study on prognosis of ovarian cancer in Japan. Nihon Sanka
Fukinka Gakki Zasshi. 44:827–832. 1992.(In Japanese).
|
6
|
O’Brien ME, Schofield JB, Tan S, et al:
Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis
only in early stages. Gynecol Oncol. 49:250–254. 1993.PubMed/NCBI
|
7
|
Sugiyama T, Kamura T, Kigawa J, et al:
Clinical characteristics of clear cell carcinoma of the ovary: a
distinct histologic type with poor prognosis and resistance to
platinum-based chemotherapy. Cancer. 88:2584–2589. 2000. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lam KY and Tang V: Metastatic tumors to
the spleen: a 25-year clinicopathologic study. Arch Pathol Lab Med.
124:526–530. 2000.PubMed/NCBI
|
9
|
Izuishi K, Sano T, Usuki H, et al:
Isolated splenic metastasis of ovarian cancer 20 years after
operation: a case report and literature review. Tumor. 96:784–786.
2010.PubMed/NCBI
|
10
|
Ghani AA, Hashmi ZA, Chase DM, et al:
Intraparenchymal metastases to the spleen from ovarian cancer: a
case report. J Med Case Rep. 4:302010. View Article : Google Scholar
|
11
|
Yano H, Iwazawa T, Kinuta M, et al:
Solitary splenic metastasis from ovarian cancer successfully
treated by hand-assisted laparoscopic splenectomy: report of a
case. Surg Today. 32:750–752. 2002. View Article : Google Scholar : PubMed/NCBI
|
12
|
Koh YS, Kim JC and Cho CK: Splenectomy for
solitary splenic metastasis of ovarian cancer. BMC Cancer.
4:962004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Yoshioka R, Okabayashi T, Nishimori I, et
al: A long-survived case with solitary splenic metastasis from
ovarian carcinoma. Surg Technol Int. 17:192–194. 2008.PubMed/NCBI
|
14
|
Alloni R, Garberini A, Caputo D and
Coppola R: Solitary splenic metastasis of ovarian carcinoma: report
of two cases. Surg Today. 38:1144–1147. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Furukawa N: Solitary splenic metastasis of
ovarian cancer. Arch Gynecol Obstet. 275:499–502. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ushijima K, Nishida T, Okura N, et al:
Solitary splenic recurrence of ovarian cancer: case report and
review of the literature. Arch Gynecol Obstet. 263:79–81. 1999.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Valbuena JR, Levenback C, Mansfield P and
Liu J: Angiosarcoma of the spleen clinically presenting as
metastatic ovarian cancer. A case report and review of the
literature. Ann Diagn Pathol. 9:289–292. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Otrock ZK, Seoud MA, Khalifeh MJ, et al:
Laparoscopic splenectomy for isolated parenchymal splenic
metastasis of ovarian cancer. Int J Gynecol Cancer. 16:1933–1935.
2006. View Article : Google Scholar : PubMed/NCBI
|
19
|
Olsen AB, Parqman S and Gillespie T:
Solitary splenic metastasis from ovarian carcinosarcoma: a case
report. J Med Case Rep. 5:562011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Hasegawa H, Naitoh H, Tsuchihashi H, et
al: A case of solitary splenic metastasis from an ovarian cancer 12
years after primary resection. Gan To Kagaku Ryoho. 37:1799–1803.
2010.(In Japanese).
|
21
|
Teilum G: Gonocytoma homologous ovarian
and testicular tumours. Acta Pathol Microbiol Scand. 23:242–251.
1946.
|
22
|
Scully RE: Recent progress in ovarian
cancer. Hum Pathol. 1:73–98. 1970. View Article : Google Scholar
|
23
|
Serov SF, Scully RE and Sobin LH:
International histologic classification of tumours. (9)Histologic
typing of ovarian tumours. World Health Organization; Geneva:
1973
|
24
|
Tan DS and Kaye S: Ovarian clear cell
adenocarcinoma: a continuing enigma. J Clin Pathol. 60:355–360.
2007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Miyamoto M, Takano M, Goto T, et al: Clear
cell histology as a poor prognostic factor for advanced epithelial
ovarian cancer: a single institutional case series through central
pathologic review. J Gynecol Oncol. 24:37–43. 2013. View Article : Google Scholar
|
26
|
Takano M, Kikuchi Y, Yaegashi N, et al:
Clear cell carcinoma of the ovary: a retrospective multicentre
experience of 254 patients with complete surgical staging. Br J
Cancer. 94:1369–1374. 2006. View Article : Google Scholar : PubMed/NCBI
|
27
|
Morgenstern L, Rosenberg J and Geller SA:
Tumors of the spleen. World J Surg. 9:468–476. 1985. View Article : Google Scholar
|
28
|
Siler J, Hunter TB, Weiss J and Haber K:
Increased echogenicity of the spleen in benign and malignant
disease. AJR Am J Roentgenol. 134:1011–1014. 1980. View Article : Google Scholar : PubMed/NCBI
|
29
|
Capizzi PJ, Allen KB, Amerson JR and
Skandalakis JE: Isolated splenic metastasis from rectal carcinoma.
South Med J. 85:1003–1005. 1992. View Article : Google Scholar : PubMed/NCBI
|
30
|
Lauro S, Trasatti L, Capalbo C, et al:
Solitary splenic recurrence of epithelial ovarian cancer:a case
report and review. Anticancer Res. 22:3643–3645. 2002.PubMed/NCBI
|
31
|
Bristow RE, Tomacruz RS, Armstrong DK, et
al: Survival effect of maximal cytoreductive surgery for advanced
ovarian carcinoma during the platinum era: a meta-analysis. J Clin
Oncol. 20:1248–1259. 2002. View Article : Google Scholar : PubMed/NCBI
|
32
|
Spencer NJ, Spencer JA, Perren TJ and Lane
G: CT appearances and prognostic significance of splenic metastasis
in ovarian cancer. Clin Radiol. 53:417–421. 1998. View Article : Google Scholar : PubMed/NCBI
|
33
|
Senturk S, Karcaaltıncaba M and Akata D:
CT diagnosis of intrasplenic metastasis from ovarian carcinoma. Eur
J Radiol. 81:1094–1099. 2012. View Article : Google Scholar
|
34
|
Chen LM, Leuchter RS, Lagasse LD and
Karlan BY: Splenectomy and surgical cytoreduction for ovarian
cancer. Gynecol Oncol. 77:362–368. 2000. View Article : Google Scholar : PubMed/NCBI
|
35
|
Eisenkop SM, Spirtos NM, Friedman RL, et
al: Relative influences of tumor volume before surgery and the
cytoreductive outcome on survival for patients with ovarian cancer:
a prospective study. Gynecol Oncol. 90:390–396. 2003.
|
36
|
Eisenkop SM, Spirtos NM and Lin WCM:
Splenectomy in the context of primary cytoreductive operations for
advanced epithelial ovarian cancer. Gynecol Oncol. 100:344–348.
2006. View Article : Google Scholar : PubMed/NCBI
|
37
|
Magtibay PM, Adams PB, Silverman MB, et
al: Splenectomy as part of cytoreductive surgery in ovarian cancer.
Gynecol Oncol. 100:369–374. 2006. View Article : Google Scholar
|